linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Coforge Ltd.
 
Source DateBoard Meeting DateDetails
30 Mar 202605 May 2026 Interim Dividend & Audited Results
23 Dec 202526 Dec 2025 Preferential Issue of shares & Inter alia, to consider and approve the proposal for raising of funds by way of issuance of equity shares or any other eligible securities through permissible modes, including but not limited to a private placement, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company and to approve ancillary actions (including convening of shareholders meeting through extraordinary general meeting or postal ballot) for the above mentioned fund raising subject to such regulatory / statutory approvals as may be required including approval of shareholders in this regard
09 Dec 202522 Jan 2026 Interim Dividend & Quarterly Results
03 Sep 202524 Oct 2025 Quarterly Results & Interim Dividend
05 Jun 202523 Jul 2025 Interim Dividend & Quarterly Results
11 Mar 202505 May 2025 Interim Dividend & Audited Results
25 Feb 202504 Mar 2025 Stock Split
04 Dec 202422 Jan 2025 Quarterly Results & Interim Dividend
16 Sep 202422 Oct 2024 Quarterly Results & Interim Dividend
04 Jun 202422 Jul 2024 Quarterly Results & Interim Dividend
22 May 202427 May 2024 Inter alia, for considering and approving the Issue Price for the Equity Shares to be allotted to qualified institutional buyer
15 Apr 202402 May 2024 Quarterly Results & Interim Dividend & Audited Results
13 Mar 202416 Mar 2024 inter alia consider and approve the proposal for raising of funds by way of issuance equity shares or any other eligible securities through permissible modes, including but not limited to a private placement, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company and to approve ancillary actions (including convening of shareholders meeting through extraordinary general meeting or postal ballot) for the above mentioned fund raising subject to such regulatory / statutory approvals as may be required including approval of shareholders in this regard.
12 Mar 202402 May 2024 Interim Dividend & Audited Results & Quarterly Results
04 Dec 202322 Jan 2024 Quarterly Results & Interim Dividend
01 Sep 202319 Oct 2023 Interim Dividend & Quarterly Results
01 Jun 202320 Jul 2023 Interim Dividend & Quarterly Results
03 Mar 202327 Apr 2023 Audited Results & Fourth Interim Dividend
09 Nov 202220 Jan 2023 Quarterly Results & Interim Dividend
29 Sep 202220 Oct 2022 Quarterly Results & Interim Dividend
Page 1 of 5
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.